Benitec Biopharma Inc.
BNTCNasdaqCIK 1808898HealthcareFiscal year ends Dec 31
Reports and events: 136 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-09-2616:30 ET | 10-K | Annual reportPeriod 2024-06-30 | 0001193125-24-226968 |
| 2024-09-0520:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-213348 |
| 2024-07-2916:28 ET | DEF 14A | Proxy statementPeriod 2024-08-29 | 0001193125-24-187599 |
| 2024-07-1517:18 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-179108 |
| 2024-07-0116:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-173338 |
| 2024-05-1619:32 ET | S-1 | Registration statement | 0001193125-24-139625 |
| 2024-05-1308:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-136730 |
| 2024-05-1308:01 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001193125-24-136727 |
| 2024-04-2916:08 ET | SC 13D | Ownership report, active investor | 0000899140-24-000506 |
| 2024-04-1921:45 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-101289 |
| 2024-04-1808:53 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-100080 |
| 2024-03-0816:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-063667 |
| 2024-02-1308:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-032956 |
| 2024-02-1308:01 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0001193125-24-032940 |
| 2023-12-0716:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-290709 |
| 2023-11-3007:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-285671 |
| 2023-11-1308:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-275384 |
| 2023-11-1308:00 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001193125-23-275377 |
| 2023-10-2006:04 ET | DEF 14A | Proxy statementPeriod 2023-12-06 | 0001193125-23-259531 |
| 2023-10-1617:29 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-257001 |
| 2023-09-2817:19 ET | 8-K | 8.01 Other events | 0001193125-23-245807 |
| 2023-09-2108:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-239127 |
| 2023-09-2108:00 ET | 10-K | Annual reportPeriod 2023-06-30 | 0001193125-23-239121 |
| 2023-09-1817:26 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-237014 |
| 2023-08-1116:01 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-210679 |
| 2023-08-1016:42 ET | 8-K | 3.01 Delisting notice | 0001193125-23-209112 |
| 2023-08-0708:11 ET | S-1/A | Registration statement, amended | 0001193125-23-204498 |
| 2023-08-0308:27 ET | S-1/A | Registration statement, amended | 0001193125-23-202324 |
| 2023-07-3108:34 ET | S-1/A | Registration statement, amended | 0001193125-23-198629 |
| 2023-07-2514:08 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-193295 |
| 2023-07-0716:52 ET | S-1 | Registration statement | 0001193125-23-183854 |
| 2023-06-2608:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-174479 |
| 2023-06-1516:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-167929 |
| 2023-05-1508:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-144217 |
| 2023-05-1508:01 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001193125-23-144211 |
| 2023-03-0816:31 ET | 8-K | 3.01 Delisting notice | 0001193125-23-064582 |
| 2023-02-1308:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-034348 |
| 2023-02-1308:02 ET | 10-Q | Quarterly reportPeriod 2022-12-31 | 0001193125-23-034339 |
| 2023-01-2308:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-012670 |
| 2022-12-1319:54 ET | S-1 | Registration statement | 0001193125-22-303006 |
| 2022-12-1207:53 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-22-302288 |
| 2022-12-0816:16 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-22-301044 |
| 2022-11-1008:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-281980 |
| 2022-11-1008:00 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001193125-22-281978 |
| 2022-10-2516:15 ET | DEF 14A | Proxy statementPeriod 2022-12-07 | 0001193125-22-268377 |
| 2022-10-1816:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-264446 |
| 2022-09-1608:58 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-246077 |
| 2022-09-1216:20 ET | S-1/A | Registration statement, amended | 0001193125-22-242886 |
| 2022-09-0921:27 ET | S-1/A | Registration statement, amended | 0001193125-22-241222 |
| 2022-09-0716:16 ET | 8-K | 3.01 Delisting notice | 0001193125-22-240014 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:28 ET. Listed shows no prices and gives no investment advice.